These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
354 related items for PubMed ID: 25148681
21. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease. Crestini A, Santilli F, Martellucci S, Carbone E, Sorice M, Piscopo P, Mattei V. J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675 [Abstract] [Full Text] [Related]
22. Ca(2+)/calmodulin-dependent protein kinase II interacts with group I metabotropic glutamate and facilitates receptor endocytosis and ERK1/2 signaling: role of β-amyloid. Raka F, Di Sebastiano AR, Kulhawy SC, Ribeiro FM, Godin CM, Caetano FA, Angers S, Ferguson SS. Mol Brain; 2015 Mar 26; 8():21. PubMed ID: 25885040 [Abstract] [Full Text] [Related]
23. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers. Jarosz-Griffiths HH, Corbett NJ, Rowland HA, Fisher K, Jones AC, Baron J, Howell GJ, Cowley SA, Chintawar S, Cader MZ, Kellett KAB, Hooper NM. J Biol Chem; 2019 Apr 26; 294(17):7085-7097. PubMed ID: 30872401 [Abstract] [Full Text] [Related]
24. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease. Haas LT, Salazar SV, Kostylev MA, Um JW, Kaufman AC, Strittmatter SM. Brain; 2016 Feb 26; 139(Pt 2):526-46. PubMed ID: 26667279 [Abstract] [Full Text] [Related]
25. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. Chen S, Yadav SP, Surewicz WK. J Biol Chem; 2010 Aug 20; 285(34):26377-83. PubMed ID: 20576610 [Abstract] [Full Text] [Related]
26. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laurén J, Gimbel ZA, Strittmatter SM. J Neurosci; 2010 May 05; 30(18):6367-74. PubMed ID: 20445063 [Abstract] [Full Text] [Related]
27. Aptamer-Induced-Dimerization Strategy Attenuates AβO Toxicity through Modulating the Trophic Activity of PrPC Signaling. Liu S, Li S, Lin J, Li J, Yang H. J Am Chem Soc; 2022 Jun 01; 144(21):9264-9270. PubMed ID: 35583938 [Abstract] [Full Text] [Related]
29. Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes. Hamilton A, Zamponi GW, Ferguson SS. Mol Brain; 2015 Mar 24; 8():18. PubMed ID: 25888324 [Abstract] [Full Text] [Related]
30. Soluble Prion Peptide 107-120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer's Disease. Rezvani Boroujeni E, Hosseini SM, Fani G, Cecchi C, Chiti F. Int J Mol Sci; 2020 Oct 01; 21(19):. PubMed ID: 33019683 [Abstract] [Full Text] [Related]
31. Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay. Risse E, Nicoll AJ, Taylor WA, Wright D, Badoni M, Yang X, Farrow MA, Collinge J. J Biol Chem; 2015 Jul 03; 290(27):17020-8. PubMed ID: 25995455 [Abstract] [Full Text] [Related]
32. Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity. Peters C, Espinoza MP, Gallegos S, Opazo C, Aguayo LG. Neurobiol Aging; 2015 Mar 03; 36(3):1369-77. PubMed ID: 25599875 [Abstract] [Full Text] [Related]
33. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. Nat Neurosci; 2012 Sep 03; 15(9):1227-35. PubMed ID: 22820466 [Abstract] [Full Text] [Related]
34. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates. Béland M, Bédard M, Tremblay G, Lavigne P, Roucou X. Neurobiol Aging; 2014 Jul 03; 35(7):1537-48. PubMed ID: 24602510 [Abstract] [Full Text] [Related]
35. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model. Hamilton A, Vasefi M, Vander Tuin C, McQuaid RJ, Anisman H, Ferguson SS. Cell Rep; 2016 May 31; 15(9):1859-65. PubMed ID: 27210751 [Abstract] [Full Text] [Related]
36. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Um JW, Strittmatter SM. Prion; 2013 May 31; 7(1):37-41. PubMed ID: 22987042 [Abstract] [Full Text] [Related]
37. Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists. Gunther EC, Smith LM, Kostylev MA, Cox TO, Kaufman AC, Lee S, Folta-Stogniew E, Maynard GD, Um JW, Stagi M, Heiss JK, Stoner A, Noble GP, Takahashi H, Haas LT, Schneekloth JS, Merkel J, Teran C, Naderi ZK, Supattapone S, Strittmatter SM. Cell Rep; 2019 Jan 02; 26(1):145-158.e8. PubMed ID: 30605671 [Abstract] [Full Text] [Related]
38. α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Ferreira DG, Temido-Ferreira M, Vicente Miranda H, Batalha VL, Coelho JE, Szegö ÉM, Marques-Morgado I, Vaz SH, Rhee JS, Schmitz M, Zerr I, Lopes LV, Outeiro TF. Nat Neurosci; 2017 Nov 02; 20(11):1569-1579. PubMed ID: 28945221 [Abstract] [Full Text] [Related]
39. Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. Nygaard HB, Strittmatter SM. Arch Neurol; 2009 Nov 02; 66(11):1325-8. PubMed ID: 19901162 [Abstract] [Full Text] [Related]
40. A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein. Massignan T, Cimini S, Stincardini C, Cerovic M, Vanni I, Elezgarai SR, Moreno J, Stravalaci M, Negro A, Sangiovanni V, Restelli E, Riccardi G, Gobbi M, Castilla J, Borsello T, Nonno R, Biasini E. Sci Rep; 2016 Mar 15; 6():23180. PubMed ID: 26976106 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]